A Pfizer-BioNTech COVID-19 vaccine trial for children aged between five and 11 has produced "positive results" and has shown a "robust immune response", the two firms have said.
Full ArticlePfizer COVID vaccine trial for children aged under 12 shows 'robust immune response'
Sky News
0 shares
2 views
You might like
Related news coverage
Pfizer seeks FDA clearance for COVID-19 vaccine in younger children
Jerusalem Post
The vaccine, which is already authorized in teens aged 12 to 15 and fully approved for ages 16 and up, has been shown to induce a..
Advertisement
More coverage
Pfizer Announces COVID-19 Vaccine Safe For Kids Ages 5 – 11
cbs4.com
Pfizer announced Monday that a medical trial shows its coronavirus vaccine is "safe" for children ages five to 11.